Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/6634 stock hub

TPEX/6634 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TPEX/6634is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
3.9B
Taipei Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TPEX/6634
In the news

Latest news · TPEX/6634

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12P50 15.5P75 22.5
Trailing P/En/a
P25 14.4P50 18P75 31.9
ROE-10.8
P25 -16.2P50 0.3P75 9.8
ROIC-7.6
P25 -11.7P50 -0.2P75 8.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TPEX/6634 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
167
Groups with data
11
Currency
TWD
Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Taiwan
Country code
TW
Employees
57
Employees Change
5%
Employees Change Percent
9.62
Enterprise value
TWD 2.9B
Exchange
Taipei Exchange
Financial currency
TWD
First seen
2026-05-10
Industry
Biotechnology
Isin
TW0006634009
Last refreshed
2026-05-10
Market cap
TWD 3.9B
Price
TWD 54.7
Price currency
TWD
Rev Per Employee
824.56x
Sector
Healthcare
Sic
2834
Symbol
tpex/6634
Website
https://www.sinewpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

6
MetricValue
Earnings Yield
-3.17%
EV Earnings
-23.13x
EV/FCF
-29.84x
FCF yield
-2.46%
P/B ratio
3.57x
P/S ratio
82,968.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

13
MetricValue
Gross margin
78.72%
Gross Profit
TWD 37,000
Net Income
TWD -123.7M
Net Income Growth Quarters
1%
Net Income Growth Years
2%
Pretax Margin
-263,287.23%
Profit Per Employee
TWD -2.2M
ROA
-7.44
Roa5y
-7.12
ROCE
-12.71
ROE
-10.81
Roe5y
-10.69
ROIC
-7.59

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

6
MetricValue
Cagr1y
23.08%
Cagr3y
-13.08%
Cagr5y
-8.51%
EPS Growth Quarters
1
EPS Growth Years
2
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
TWD 0
Assets
TWD 1.1B
Cash
TWD 1.1B
Current Assets
TWD 1.1B
Current Liabilities
TWD 25.5M
Debt
TWD 15.2M
Debt Equity
TWD 0.01
Debt FCF
TWD -0.16
Equity
TWD 1.1B
Interest Coverage
-213.3
Liabilities
TWD 36.4M
Long Term Assets
TWD 50.2M
Long Term Liabilities
TWD 10.9M
Net Cash
TWD 1B
Net Cash By Market Cap
TWD 26.59
Net Cash Growth
-10.32%
Net Debt Equity
TWD -0.95
Tangible Book Value
TWD 1.1B
Tangible Book Value Per Share
TWD 15.09
WACC
5.12

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
42.27
Net Working Capital
TWD 5.7M
Quick ratio
42.23
Working Capital
TWD 1.1B
Working Capital Turnover
TWD 0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
0.37%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
23.06%
200-day SMA
41.83
3Y total return
-34.33%
50-day SMA
36.19
50-day SMA vs 200-day SMA
50under200
5Y total return
-35.91%
All Time High
176
All Time High Change
-68.92%
All Time High Date
2020-07-07
All Time Low
12.95
All Time Low Change
322.39%
All Time Low Date
2018-12-14
ATR
3.6
Beta
0.16
Beta1y
0.37
Beta2y
0.19
Ch YTD
39.72
High
56.7
High52
56.7
High52 Date
2026-05-08
High52ch
-3.19%
Low
52.1
Low52
29.05
Low52 Date
2026-04-13
Low52ch
88.3%
Ma50ch
51.17%
Price vs 200-day SMA
30.78%
RSI
74.74
RSI Monthly
53.07
RSI Weekly
68.2
Sharpe ratio
0.53x
Sortino ratio
1.17
Total Return
0.37%
Tr YTD
39.72
Tr1m
72.83%
Tr1w
10.06%
Tr3m
43.95%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
TWD -140.1M
Operating margin
-298,140.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
42,495,625%
Net Borrowing
-6,221,000
Shares Insiders
17.8%
Shares Institutions
3.23%
Shares Out
71,288,930
Shares Qo Q
0.07%
Shares Yo Y
-0.37%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

50
MetricValue
Adjusted FCF
TWD -112.9M
Average Volume
241,416.25x
Bv Per Share
15.31
CAPEX
TWD -634,000
Ch1m
72.83
Ch1w
10.06
Ch1y
23.06
Ch3m
43.95
Ch3y
-34.33
Ch5y
-37.77
Ch6m
27.95
Change
4.79%
Change From Open
4.79
Close
52.2
Days Gap
0
Depreciation Amortization
12,991,000
Dollar Volume
28,521,181.7
Earnings Date
2026-08-13
EBIT
TWD -140.1M
EBITDA
TWD -127.1M
EPS
TWD -1.74
F Score
1
FCF
TWD -95.9M
FCF EV Yield
-3.35x
FCF Per Share
TWD -1.35
Financing CF
-5,576,000
Fiscal Year End
December
Founded
2,014
Investing CF
84,752,000
Is Primary Listing
1
Last Earnings Date
2025-11-14
Last Report Date
2025-12-31
Ma150
39.34
Ma150ch
39.03%
Ma20
39.24
Ma20ch
39.39%
Net CF
-16,123,000
Next Earnings Date
2026-08-13
Open
52.2
Position In Range
56.52
Ppne
17,046,000
Price Date
2026-05-08
Ptbv Ratio
3.62
Relative Volume
2.43x
Revenue
47,000x
SBC By Revenue
36,182.98x
Share Based Comp
17,006,000
Tr6m
27.95%
Volume
521,411
Z Score
55.92
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TPEX/6634 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/6634 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+23.1%
S&P 500 1Y: n/a
3Y total return
-34.3%
S&P 500 3Y: n/a
5Y total return
-35.9%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns TPEX/6634?

Insider, institutional, and short-interest positioning.

Institutional ownership
+3.2%
Share of float held by funds and institutions
Insider ownership
+17.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.4%
Negative means the company is buying back shares.
Technical

TPEX/6634 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
74.7
Above 70: short-term overbought
Price vs 200-day MA
+30.8%
50/200-day relationship not available
Beta (5Y)
0.16
Less volatile than the market
Sharpe ratio
0.53
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TPEX/6634

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6634 stock rating?

tpex/6634 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6634 analysis?

The full report lives at /stocks/tpex/6634/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6634?

The latest report frames tpex/6634 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6634 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.